to assess the role of endogenous opioids in the pathogenesis of apnea in children , the effect of oral treatment with the opioid antagonist naltrexone was studied in apneic infants , as well as in older apneic children , with demonstrated increases in csf immunoreactive beta-endorphin ( i-be ) .
C0008059
children
C1455726
older